MGRX vs NRG · rev $456.0K vs P/E 145, rev $17.74B
Mangoceuticals, Inc. Common Stock (MGRX) versus NRG Energy Inc. (NRG) — a side-by-side from cached financials, not a winner call.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
NRG Energy Inc. (NRG) is a utilities - independent power producers company listed on NYSE.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
Latest reported NRG revenue for 2026-06-30 was $17.74B. Net income was $631.0M. Revenue was up 72.9% from 2026-03-31 to 2026-06-30. NRG currently screens at market cap $27.88B and trailing P/E 145.2.
MGRX currently screens at market cap $16.3M. NRG currently screens at market cap $27.88B and trailing P/E 145.2.
Not investment advice. Open the MGRX and NRG stock pages for the full models.
Not investment advice.